UPLOAD Filing
Terns Pharmaceuticals, Inc.
Date: May 15, 2025 · CIK: 0001831363 · Accession: 0000000000-25-005214
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-287092
Letter
Re: Terns Pharmaceuticals, Inc. Registration Statement on Form S-3 Filed May 8, 2025 File No. 333-287092 Dear Amy Burroughs:
May 15, 2025
Amy Burroughs Chief Executive Officer and Director Terns Pharmaceuticals, Inc. 1065 East Hillsdale Blvd., Suite 100 Foster City, CA 94404
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Daniel Crawford at 202-551-7767 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> May 15, 2025 Amy Burroughs Chief Executive Officer and Director Terns Pharmaceuticals, Inc. 1065 East Hillsdale Blvd., Suite 100 Foster City, CA 94404 Re: Terns Pharmaceuticals, Inc. Registration Statement on Form S-3 Filed May 8, 2025 File No. 333-287092 Dear Amy Burroughs: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Daniel Crawford at 202-551-7767 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences </TEXT> </DOCUMENT>